Natural approach to hypertension

Alternative Medicine Review

Volumn 6, Issue 6, 2001, Pages 590-600

  Khosh, F ^a   Khosh, M ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE MEDICINE; ANTIHYPERTENSIVE ACTIVITY; ANTIHYPERTENSIVE THERAPY; COPING BEHAVIOR; DIET THERAPY; EXERCISE; HUMAN; HYPERTENSION; REVIEW; STRESS; UNITED STATES;

COMPLEMENTARY THERAPIES; DIET; DIETARY SUPPLEMENTS; HUMANS; HYPERTENSION; LIFE STYLE; PHYTOTHERAPY;

EID: 0035674582     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (75)

1. Hypertensive cardiovascular disease in African Americans
2. Does the evidence from clinical trials justify the treatment of hypertension?
3. Epidemiology of high blood pressure
4. Normal values of blood pressure self-measurement in view of the 1999 World Health Organization-International Society of Hypertension guidelines
5. High blood pressure
6. Evaluation of drug prescription in the primary care clinic in Geneva in 1997
7. The effect of dietary patterns on blood pressure control in hypertensive patients: Results from the Dietary Approaches to Stop Hypertension (DASH) trial
8. Obesity as a chronic disease: Modern medical and lifestyle management
9. Effects of insufficient sleep on blood pressure in hypertensive patients: A 24-h study
10. Reduction in drug requirements for hypertension by means of a cognitive-behavioral intervention
11. Effect of potassium intake on blood pressure
12. Increased blood pressure during potassium depletion in normotensive men
13. Effects of potassium on blood pressure control
14. Potassium in hypertension
15. Dietary sodium chloride and potassium have effects on the pathophysiology of hypertension in humans and animals
16. Potassium in preventing and treating high blood pressure
17. Effect of oral magnesium supplementation on blood pressure, platelet aggregation and calcium handling in deoxycorticosterone acetate induced hypertension in rats
18. Nutritional dose of magnesium in hypertensive patients on beta blockers lowers systolic blood pressure: A double-blind, cross-over study
19. The dose-dependent reduction in blood pressure through administration of magnesium. A double blind placebo controlled cross-over study
20. Overview of the use of CoQ10 in cardiovascular disease
21. Usefulness of coenzyme Q10 in clinical cardiology: A long-term study
22. Isolated diastolic dysfunction of the myocardium and its response to CoQ10 treatment
23. Bioenergetics in clinical medicine. XVI. Reduction of hypertension in patients by therapy with coenzyme Q10
24. Bioenergetics in clinical medicine. VIII. Adminstration of coenzyme Q10 to patients with essential hypertension
25. Treatment of essential hypertension with coenzyme Q10
26. Coenzyme Q10 in essential hypertension
27. Docosahexaenoic acid, a peroxisome proliferator-activated receptor-alpha ligand, induces apoptosis in vascular smooth muscle cells by stimulation of p38 mitogen-activated protein kinase
28. Calcium-mediated mechanisms of eicosapentaenoic acid-induced relaxation in hypertensive rat aorta
29. Effect of docosahexaenoic acid on intracellular calcium dynamics in vascular smooth muscle cells from normotensive and genetically hypertensive rats
30. Effect of docosahexaenoic acid on smooth muscle cell functions
31. Effect of medium-term supplementation with a moderate dose of n-3 polyunsaturated fatty acids on blood pressure in mild hypertensive patients
32. One-year treatment with ethyl esters of n-3 fatty acids in patients with hypertriglyceridemia and glucose intolerance: Reduced triglyceridemia, total cholesterol and increased HDL-C without glycemic alterations
33. Cardiovascular disease and omega-3 fatty acids
34. Fish consumption and coronary heart disease mortality in Finland, Italy, and The Netherlands
35. N-3 fatty acids from fish and coronary artery disease: Implications for public health
36. N-3 fatty acids and the prevention of coronary atherosclerosis
37. Quantitative study of myocardial microcirculation in arterial hypertension due to progressive inhibition of NO synthesis
38. Blood pressure and metabolic changes during dietary L-arginine supplementation in humans
39. Taurine attenuates hypertension and improves insulin sensitivity in the fructose-fed rat, an animal model of insulin resistance
40. Effects of increased adrenomedullary activity and taurine in young patients with borderline hypertension
41. Influence of endogenous opiates on the hypotensive action of taurine in DOCA-salt rats
42. Hypotensive effect of taurine. Possible involvement of the sympathetic nervous system and endogenous opiates
43. How does ascorbic acid prevent endothelial dysfunction?
44. Treatment of hypertension with ascorbic acid
45. Alpha-Tocopherol increased nitric oxide synthase activity in blood vessels of spontaneously hypertensive rats
46. Crataegus Special Extract WS 1442 in NYHA II heart failure. A placebo controlled randomized double-blind study
47. Myocardial effects of flavonoids from Crataegus species
48. Procyanidins in crataegus extract evoke endothelium-dependent vasorelaxation in rat aorta
49. Terminalia arjuna
50. Antianginal and cardioprotective effects of Terminalia arjuna, an indigenous drug, in coronary artery disease
51. Salutary effect of Terminalia arjuna in patients with severe refractory heart failure
52. Beneficial effects of Terminalia arjuna in coronary artery disease
53. Oleuropein, the bitter principle of olives, enhances nitric oxide production by mouse macrophages
54. Oleuropein, an antioxidant polyphenol from olive oil, is poorly absorbed from isolated perfused rat intestine
55. A clinical trial of a titrated olea extract in the treatment of essential arterial hypertension
56. Vasodilator effect of olive leaf
57. Studies on pharmacological activity of the Japanese and European mistletoe
58. Plants and hypotensive, antiatheromatous and coronarodilatating action
59. Antihypertensive and antihyperlipidemic effects of Achillea wilhelmsii
60. Diuretic and hypotensive effects of Nigella sativa in the spontaneously hypertensive rat
61. High performance liquid chromatographic analysis of the pharmacologically active quinones and related compounds in the oil of the black seed (Nigella sativa L.)
62. The cardiovascular actions of the volatile oil of the black seed (Nigella sativa) in rats: Elucidation of the mechanism of action
63. Antioxidant activity of Nigella sativa essential oil
64. The positive inotropic-acting forskolin, a potent adenylate cyclase activator
65. Pharmacological studies on coleonol, a hypotensive diterpene from Coleus forskohlii
66. Selective depleting effect of syrosingopine on brain catecholamine levels with relation to morphine analgesia in the rat
67. Treatment of mild hypertension: Results of a ten-year intervention trial
68. Cardiovascular effects of ajmaline
69. Antiarrhythmic activity of ajmaline obtained from Rauwolfia serpentina biomass grown in tissue culture
70. Role of elements in pathophysiology of hypertension and antihypertensive drug development
71. Pleiotropic effects of garlic
72. Can garlic lower blood pressure? A pilot study